Replies to post #125961 on Biotech Values

[genisi]

Ideally, yes it would. Still the amount of tissue required for diagnosis and all assays could be too low when only cytologic or small biopsy samples are available. CGH chip is the best way for this purpose but the cost may be a barrier in many cases.

[DewDiligence]

I believe you can screen for all for less than what Pfizer/Abbott are charging for their official fda blessed ALK Dx.

ABT is charging the testing labs about $250 per test, according to a spokesperson. The rest of the end-user price for the test goes to the testing labs.